THC Biomed Intl Ltd.

CNSX:THC Stock Report

Market Cap: CA$3.3m

THC Biomed Intl Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

John Miller

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure9.1yrs
CEO ownership19.1%
Management average tenureno data
Board average tenure8.8yrs

Recent management updates

Recent updates

Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?

Oct 11
Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?

Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?

Jun 26
Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?

Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?

Mar 13
Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?

Is THC Biomed Intl (CSE:THC) Using Too Much Debt?

Aug 30
Is THC Biomed Intl (CSE:THC) Using Too Much Debt?

We Think THC Biomed Intl (CSE:THC) Has A Fair Chunk Of Debt

Mar 25
We Think THC Biomed Intl (CSE:THC) Has A Fair Chunk Of Debt

Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?

Dec 02
Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?

Is THC Biomed Intl (CSE:THC) Using Too Much Debt?

Jun 01
Is THC Biomed Intl (CSE:THC) Using Too Much Debt?

Analysts Expect Breakeven For THC Biomed Intl Ltd. (CSE:THC) Before Long

Apr 06
Analysts Expect Breakeven For THC Biomed Intl Ltd. (CSE:THC) Before Long

Would THC Biomed Intl (CSE:THC) Be Better Off With Less Debt?

Jan 08
Would THC Biomed Intl (CSE:THC) Be Better Off With Less Debt?

CEO Compensation Analysis

How has John Miller's remuneration changed compared to THC Biomed Intl's earnings?
DateTotal CompensationSalaryCompany Earnings
Apr 30 2023n/an/a

-CA$4m

Jan 31 2023n/an/a

-CA$3m

Oct 31 2022n/an/a

-CA$3m

Jul 31 2022n/an/a

-CA$3m

Apr 30 2022n/an/a

-CA$3m

Jan 31 2022n/an/a

-CA$4m

Oct 31 2021n/an/a

-CA$6m

Jul 31 2021n/an/a

-CA$6m

Apr 30 2021n/an/a

-CA$6m

Jan 31 2021n/an/a

-CA$5m

Oct 31 2020n/an/a

-CA$2m

Jul 31 2020n/an/a

-CA$162k

Apr 30 2020n/an/a

-CA$4m

Jan 31 2020n/an/a

-CA$8m

Oct 31 2019n/an/a

-CA$13m

Jul 31 2019CA$67kCA$60k

-CA$13m

Apr 30 2019n/an/a

-CA$12m

Jan 31 2019n/an/a

-CA$7m

Oct 31 2018n/an/a

-CA$12m

Jul 31 2018CA$67kn/a

-CA$12m

Apr 30 2018n/an/a

-CA$10m

Jan 31 2018n/an/a

-CA$11m

Oct 31 2017n/an/a

-CA$1m

Jul 31 2017CA$66kCA$60k

-CA$605k

Compensation vs Market: Insufficient data to establish whether John's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.

CEO

John Miller

9.1yrs

Tenure

CA$66,750

Compensation

Mr. John Miller serves as Chief Executive Officer at THC Biomed Intl Ltd. since April 29, 2015. He is also President at THC Biomed Intl Ltd.and its Director since June 3, 2014. He was Director and Office...

Board Members

NamePositionTenureCompensationOwnership
John Miller
President9.9yrsCA$66.75k19.14%
CA$ 627.5k
Jung Hee
Co-Founder9.9yrsCA$66.66k9.89%
CA$ 324.2k
Jason Springett
Member of Advisory Board8.8yrsno datano data
Donald Shaxon
Member of Advisory Board8.8yrsno datano data
Ashish Dave
Independent Director6.9yrsCA$6.50kno data
Penelope Laine
Independent Director4.2yrsno data0.0061%
CA$ 200.0

8.8yrs

Average Tenure

Experienced Board: THC's board of directors are considered experienced (8.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/05/01 12:09
End of Day Share Price 2024/02/02 00:00
Earnings2023/04/30
Annual Earnings2022/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

THC Biomed Intl Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siddharth RajeevFundamental Research Corp.
Brian TangFundamental Research Corp.